A Veteran Bull Ready to Charge Again


Q: What's your view for the health-care sector?

A: Health care's a fairly broad sector. I'd say in the pharma arena, the large-cap companies are of limited appeal, except for J&J. The large biotech companies have appeal -- Amgen (AMGN ), Genentech (DNA ). A portfolio of small biotech companies makes sense as well.


We Almost Lost the Nasdaq
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus